CMBA
SYNH

C.M. Bidwell & Associates’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

C.M. Bidwell & Associates’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,270
Closed -$163K – 561
2022
Q2 		$163K Hold
2,270
– – 0.13% 144
2022
Q1 		$184K Hold
2,270
– – 0.12% 171
2021
Q4 		$233K Sell
2,270
-700
-24% -$67.2K 0.14% 134
2021
Q3 		$260K Sell
2,970
-500
-14% -$45.3K 0.17% 107
2021
Q2 		$311K Sell
3,470
-1,170
-25% -$98.8K 0.2% 86
2021
Q1 		$352K Sell
4,640
-50
-1% -$3.77K 0.26% 57
2020
Q4 		$320K Buy
4,690
+1,125
+32% +$70.1K 0.26% 57
2020
Q3 		$190K Buy
3,565
+1,710
+92% +$102K 0.17% 120
2020
Q2 		$108K Sell
1,855
-1,895
-51% -$102K 0.1% 201
2020
Q1 		$148K Buy
3,750
+2,520
+205% +$147K 0.16% 129
2019
Q4 		$73K Sell
1,230
-790
-39% -$42.5K 0.07% 183
2019
Q3 		$107K Buy
+2,020
New +$104K 0.11% 178

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

C.M. Bidwell & Associates's SYNH Position: Q3 2022 in Review

C.M. Bidwell & Associates sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 2,270 shares — an estimated $163K sold.

C.M. Bidwell & Associates first reported a position in SYNH in Q3 2019 and held it in 12 quarters. The position peaked at $352K in Q1 2021. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

  • C.M. Bidwell & Associates reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 2,270 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $163K.
  • C.M. Bidwell & Associates first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2019 and held it in 12 quarters.
  • C.M. Bidwell & Associates's Syneos Health, Inc. Class A Common Stock position peaked at $352K in Q1 2021.
  • 337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on C.M. Bidwell & Associates's 13F filing for Q3 2022, filed 14 Nov 2022.